Client News

Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers

MS Pharma Becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region

BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data

Galimedix Therapeutics Initiates Phase 1 Study with Oral Small Molecule, GAL-101, an Amyloid Beta (Aβ) Aggregation Modulator

Formycon Joins the SDAX of the German Stock Exchange

Medigene AG Expands Patent Portfolio with Patent Grant for its MAGE-A4 Targeted T Cell Receptor in China

Leon-Nanodrugs: Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery

Medigene AG Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.

Mainz Biomed Announces Stock Split

Formycon Reports Nine-Month Results for 2024 and Continues Growth Trajectory with Further Operational Success